Ohio Public Employees Retirement System (OPERS)’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Sell
31,378
-1,070
-3% -$23.1K ﹤0.01% 1241
2025
Q4
$815K Sell
32,448
-1,231
-4% -$28.9K ﹤0.01% 1386
2025
Q3
$762K Buy
33,679
+209
+0.6% +$4.87K ﹤0.01% 1422
2025
Q2
$579K Buy
33,470
+495
+2% +$9.16K ﹤0.01% 1465
2025
Q1
$721K Sell
32,975
-2,897
-8% -$80K ﹤0.01% 1399
2024
Q4
$1.14M Sell
35,872
-2,054
-5% -$61.8K ﹤0.01% 1318
2024
Q3
$1.09M Sell
37,926
-1,889
-5% -$70K ﹤0.01% 1222
2024
Q2
$1.53M Buy
39,815
+1,139
+3% +$51.6K 0.01% 1061
2024
Q1
$2.27M Sell
38,676
-3,646
-9% -$232K 0.01% 927
2023
Q4
$2.53M Buy
42,322
+1,700
+4% +$86.2K 0.01% 913
2023
Q3
$1.54M Sell
40,622
-4,500
-10% -$198K 0.01% 1043
2023
Q2
$4.11M Buy
+45,122
New +$3.89M 0.02% 710

Other funds holding APLS

Ohio Public Employees Retirement System (OPERS)'s APLS Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Apellis Pharmaceuticals (APLS) stake by 3.3% in Q1 2026, selling an estimated $23.1K and leaving 31,378 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

Ohio Public Employees Retirement System (OPERS) first reported a position in APLS in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.11M in Q2 2023. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 31,378 shares of Apellis Pharmaceuticals worth $1.26M as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 1,070 Apellis Pharmaceuticals shares in Q1 2026, an estimated $23.1K.
  • Apellis Pharmaceuticals made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1241 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Apellis Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Apellis Pharmaceuticals position peaked at $4.11M in Q2 2023.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.